We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant
PAVMZ

Delisted

PAVMZ was delisted on the 30th of April, 2025.

Back to rankings

7 hedge funds and large institutions have $70.4K invested in PAVmed Inc. Series Z Warrant in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

17% more funds holding

Funds holding: 6 → 7 (+1)

29% less capital invested

Capital invested by funds: $99.3K → $70.4K (-$28.9K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$13.4K
2
Bank of America
Bank of America
North Carolina
+$20

Top Sellers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
-$2.76K
2
UBS Group
UBS Group
Switzerland
-$2.15K
3
Morgan Stanley
Morgan Stanley
New York
-$220
4
RJA
Raymond James & Associates
Florida
-$79

PAVMZ Hedge Fund Activity: Q1 2023 in Review

7 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q1 2023, worth a combined $70.4K — down 29% from $99.3K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PAVMZ positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $13.4K. The largest seller was Wolverine Asset Management, cutting an estimated $2.76K.

  • 7 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q1 2023, up from 6 in Q4 2022.
  • Funds reported $70.4K of PAVmed Inc. Series Z Warrant stock for Q1 2023, down 29% quarter-over-quarter.
  • 2 funds opened new PAVmed Inc. Series Z Warrant positions in Q1 2023 and 1 closed out, a net change of +1 holder.
  • The largest PAVmed Inc. Series Z Warrant buyer in Q1 2023 was Susquehanna International Group, an estimated $13.4K added.
  • The largest PAVmed Inc. Series Z Warrant seller in Q1 2023 was Wolverine Asset Management, an estimated $2.76K sold.

Based on aggregated 13F filings for Q1 2023.